Effectiveness and safety of vedolizumab for treatment of Crohn's disease: a systematic review and meta-analysis
about
Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors.Integrin α4β7 Blockade Preferentially Impacts CCR6+ Lymphocyte Subsets in Blood and Mucosal Tissues of Naive Rhesus Macaques.An indirect comparison of ustekinumab and vedolizumab in the therapy of TNF-failure Crohn's disease patients.Cost-Effectiveness Analysis of Crohn's Disease Treatment with Vedolizumab and Ustekinumab After Failure of Tumor Necrosis Factor-α Antagonist.
P2860
Effectiveness and safety of vedolizumab for treatment of Crohn's disease: a systematic review and meta-analysis
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Effectiveness and safety of ve ...... matic review and meta-analysis
@ast
Effectiveness and safety of ve ...... matic review and meta-analysis
@en
Effectiveness and safety of ve ...... matic review and meta-analysis
@nl
type
label
Effectiveness and safety of ve ...... matic review and meta-analysis
@ast
Effectiveness and safety of ve ...... matic review and meta-analysis
@en
Effectiveness and safety of ve ...... matic review and meta-analysis
@nl
prefLabel
Effectiveness and safety of ve ...... matic review and meta-analysis
@ast
Effectiveness and safety of ve ...... matic review and meta-analysis
@en
Effectiveness and safety of ve ...... matic review and meta-analysis
@nl
P2860
P31
P3181
P356
P1476
Effectiveness and safety of ve ...... matic review and meta-analysis
@en
P2093
Beata Smela-Lipińska
Paweł Kawalec
P2860
P304
P3181
P356
10.5114/AOMS.2016.61915
P407
P577
2016-10-01T00:00:00Z